Adverse events with concomitant use of Simvastatin or Atorvastatin and thiazolidinediones

被引:13
作者
Alsheikh-Ali, AA [1 ]
Karas, RH [1 ]
机构
[1] Tufts Univ New England Med Ctr, Mol Cardiol Res Inst, Dept Med, Div Cardiol,Prevent Cardiol Ctr, Boston, MA 02111 USA
关键词
D O I
10.1016/j.amjcard.2004.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
On the basis of adverse events reported to the US Food and Drug Administration, it was observed that atorvastatin-associated adverse event reports, were 3.1 times more likely to list rosiglitazone or pioglitazone as a concomitant medication compared with simvastatin-associated adverse event reports. (C)2004 by Excerpta Medica, Inc.
引用
收藏
页码:1417 / 1418
页数:2
相关论文
共 6 条
  • [1] Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)
    Alsheikh-Ali, AA
    Abourjaily, HM
    Karas, RH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (11) : 1308 - +
  • [2] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [3] The myotoxicity of statins
    Evans, M
    Rees, A
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (04) : 415 - 420
  • [4] Combined treatment with specific ligands for PPARγ:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells
    Mu, YM
    Yanase, T
    Nishi, Y
    Takayanagi, R
    Goto, K
    Nawata, H
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 181 (1-2) : 239 - 248
  • [5] *NIH, 2003, PRESCR DRUG EXP 2001
  • [6] Thiazolidinediones: an update
    Schoonjans, K
    Auwerx, J
    [J]. LANCET, 2000, 355 (9208) : 1008 - 1010